Skip to content

Combined Use of Contact Aspiration and the Stent Retriever Technique Versus Stent Retriever Alone for Recanalisation in Acute Cerebral Infarction

Combined Use of Contact Aspiration and the Stent Retriever Technique Versus Stent Retriever Alone for Recanalisation in Acute Cerebral Infarction: the Randomized ASTER2 Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03290885
Acronym
ASTER2
Enrollment
408
Registered
2017-09-25
Start date
2017-10-16
Completion date
2020-02-28
Last updated
2020-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Ischemic Stroke

Brief summary

Mechanical thrombectomy (MT) with a stent retriever (SR) device is now the standard intervention in ischemic stroke with large vessel occlusion. Favorable outcome is strongly associated with the successful reperfusion status. New device of MT such as contact aspiration seems promising to increase reperfusion status and clinical outcome. The main hypothesis is to show the superiority of combining the use of contact aspiration with a stent retriever compared to a stent retriever alone in treatment of acute stroke due to proximal arterial occlusion. The primary endpoint is the rate of perfect reperfusion score at the end of the endovascular procedure.

Interventions

COMBINATION_PRODUCTCombined contact aspiration/Stent Retriever Technique

Combined contact aspiration/SR is performed using a balloon-guide catheter (BGC). A 0.021 to 0.027 inch inner lumen microcatheter with a 0.014 to 0.016 inch micro-wire inside is introduced into a large-bore aspiration catheter and this construct is introduced into BGC. The BGC is placed into the origin of the cervical internal carotid artery (ICA). The catheter is advanced past the thrombus over the micro-wire to allow the SR deployment. The SR is deployed across the occlusion. Then the large bore distal access catheter is advanced to contact the proximal edge of the SR. The aspiration pump is connected to the large bore distal access catheter. After at least 90 sec, the SR and the large bore distal access catheter are pulled out as an unit from the BGC and the patient. Manual aspiration is also be applied to the BGC during the pull-out manoeuver which is performed after the temporary inflation of the balloon at the tip of the BGC to ensure flow arrest into the carotid

DEVICEStent retriever technique

The technique used should be in accordance with the device instruction for use. A large bore balloon guide catheter has to be placed into the cervical ICA. A suitable delivery microcatheter is navigated over a micro-wire into the occluded major coronary artery MCA and across the occlusion. A control superselective angiogram may be used to document the extent of occlusion and thrombus. The stent retriever device is then deployed across the occlusion. After at least 90 seconds, removal should occur with proximal occlusion by inflation of the balloon guide catheter.

Sponsors

Hopital Foch
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 and older (i.e., candidates must have had their 18th birthday) * Groin puncture carried out within 8 hours of first symptoms * Neuroimaging demonstrates large vessel proximal occlusion (distal ICA through MCA bifurcation, M1 or M2) * Consenting requirements met according to French laws. * With or without intravenous thrombolysis

Exclusion criteria

* Absence of large vessel occlusion on non-invasive imaging * Known or suspected pre-existing (chronic) large vessel occlusion in the symptomatic territory * Suspected pregnancy; if, a woman is of childbearing potential, a urine or serum beta human chorionic gonadotropin (betaHCG) test is positive. * Severe contrast medium allergy or absolute contraindication to iodinated agents. * Patient has severe or fatal comorbidities that will likely prevent improvement or follow-up or that will render the procedure unlikely to benefit the patient. * Acute ischemic stroke involving posterior circulation (vertebrobasilar occlusion) * Angiographic evidence of carotid dissection or tandem cervical occlusion or stenosis requiring treatment. * Patients benefiting from a legal protection * Non-membership of a national insurance scheme * Opposition of the patient or (in case of inclusion as a matter of urgency) of the trustworthy person

Design outcomes

Primary

MeasureTime frameDescription
Perfect reperfusion rate24 hoursPerfect reperfusion rate at the end of angiography defined as a Thrombolysis In Cerebral Infarction (TICI) 2c/3 score (TICI score = Thrombolysis In Cerebral Infarction)

Secondary

MeasureTime frameDescription
Rate of perfect (mTICI 2c/3), successful reperfusion (mTICI 2b/2c/3), and complete reperfusion (mTICI3) after the frontline strategy24 hours
Time from groin puncture to achieve TICI 2c or better revascularization24 hoursTime from groin puncture to achieve TICI 2c or better revascularization
Time between groin puncture to clot contact and clot contact to maximum reperfusion24 hoursTime between groin puncture to clot contact and clot contact to maximum reperfusion
Modified Rankin scale (mRs)90 daysGlobal disability assessed by overall distribution of mRs at 90-days
Rate of favorable functional independence90 daysRate of favorable functional independence defined as a mRS 0-2 at 90 days
Rate of excellent functional outcome90 daysRate of excellent functional outcome defined as a Modified Rankin scale (mRS) 0-1 at 90 days
Rate of successful reperfusion24 hoursRate of successful reperfusion (mTICI 2b/2c/3), and complete reperfusion (mTICI3) at end of endovascular procedure
Rate of symptomatic and asymptomatic intracerebral hemorrhage24 hoursRate of symptomatic and asymptomatic intracerebral hemorrhage at MRI 24h after thrombectomy (according the third European Cooperative Acute Stroke Study (ECASS3) classification) (independent core lab adjudication).
Rate of parenchymal hematoma90 days
Rate of all-cause mortality90 days
Rate of periprocedural complications90 days\- Rate of periprocedural complications: Occurrence of emboli to new territory (ENT), vasospasm, dissection, or perforation.
Average cost per patient90 daysAverage cost per patient with complete recanalization
NIHSS score24 hoursChange in NIHSS from baseline to 24 hours (delta NIHSS)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026